aldesleukin

FDA Drug Profile — PROLEUKIN

aldesleukin is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including PROLEUKIN. Available dosage form: injection, powder, lyophilized, for solution.

Drug details

Generic Name
aldesleukin
Brand Names
PROLEUKIN
Application Number
BLA103293
Sponsor
Iovance Biotherapeutics, Inc
NDC Codes
1
Dosage Forms
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients
ALDESLEUKIN

Indications and Usage

1 INDICATIONS AND USAGE Proleukin is a lymphocyte growth factor indicated for: The treatment of adults with metastatic renal cell carcinoma. ( 1.1 ) The treatment of adults with metastatic melanoma. ( 1.2 ) 1.1 Metastatic Renal Cell Carcinoma Proleukin is indicated for the treatment of adults with metastatic renal cell carcinoma (RCC). 1.2 Metastatic Melanoma Proleukin is indicated for the treatment of adults with metastatic melanoma.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.